✦ LIBER ✦

Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model

✍ Scribed by Yuen, J S P; Sim, M Y; Siml, H G; Chong, T W; Lau, W K O; Cheng, C W S; Huynh, H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GSK-3 inhibition in vitro and in vivo en

✍ Hisashi Kawazoe; Vladimir N. Bilim; Andrey V. Ugolkov; Kaori Yuuki; Sei Naito; A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 739 KB

856 SORAFENIB IN PATIENTS WITH ADVANCED

✍ S. Negrier; E. Jäger; C. Porta; D. Me Dermott; M. Moore; J. Bellmunt; M.O. Grimm 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 315 KB

P030 An ERK-inhibitor AZD6244 (ARRY-1428

✍ Yuen, J.; Sim, Y.; Huynh, H. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

PCN110 A RETROSPECTIVE CLAIMS DATABASE C

✍ S Keefe; E Moyneur; V Barghout; KT Flaherty 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

252 RETROSPECTIVE ANALYSIS OF THE SEQUEN

✍ C. Porta; G. Procopio; R. Sabbatini; A. Bearz; I. Chiappino; I. Imarisio; V. Gua 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 517 KB

7130 Efficacy and safety of sorafenib in

✍ Bukowski, R.; Eisen, T.E.; Stadler, W.S.; Szczylik, C.S.; Oudard, O.S.; Siebels, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB